Claims for Patent: 9,750,206

Summary for Patent: 9,750,206

Title:	HO/LL canola with resistance to clubroot disease
Abstract:	This disclosure concerns a plant of the genus, Brassica, or parts thereof, which comprise one or more traits selected from the group consisting of high oleic acid content, low linolenic acid content, increased herbicide resistance, restorer of cytoplasmic male sterility, and increased clubroot disease (Plasmodiophora brassicae) resistance, compared to a wild-type plant of the same species. This disclosure further relates to wild-type and mutant alleles of genes involved in these traits, molecular markers linked thereto, and methods of their use.
Inventor(s):	Gingera; Gregory R. (Saskatoon, CA), Zhao; Jianwei (Saskatoon, CA), Ripley; Van Leonard (Grandora, CA), Ubayasena; Lasantha (Lafayette, IN)
Assignee:	Dow AgroSciences LLC (Indianapolis, IN)
Application Number:	13/842,535
Patent Claims:	1. A method for identifying a clubroot resistant plant comprising a mutation in a fad3 gene contributing to a low linolenic acid phenotype in Brassica napus, the method comprising: isolating genomic DNA comprising a clubroot resistance gene from a plant; determining the presence in the isolated genomic DNA of a polynucleotide that is amplified in a polymerase chain reaction by the primers of SEQ ID NO:18 and SEQ ID NO:19 and is 300 nucleotides in length; and determining the presence in the isolated genomic DNA of a polynucleotide that is specifically hybridizable with the complement of SEQ ID NO:12, wherein the polynucleotide comprises a single nucleotide polymorphism (SNP) nucleic acid molecular marker that is an adenine at the position corresponding to the first base of a 5' splice site in the third intron of the Brassica napus fad32 gene contributing to a low linolenic acid phenotype in Brassica napus. 2. The method according to claim 1, wherein determining the presence in the isolated genomic DNA of the polynucleotide that is specifically hybridizable with the complement of SEQ ID NO:12 comprises contacting the isolated genomic DNA with an oligonucleotide comprising the nucleotide sequence of SEQ ID NO:15. 3. The method according to claim 1, wherein the polynucleotide that is specifically hybridizable with the complement of SEQ ID NO:12 is not hybridizable with the complement of SEQ ID NO:13.

Details for Patent 9,750,206

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2031-02-09
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2031-02-09
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2031-02-09